» Authors » Christopher Corless

Christopher Corless

Explore the profile of Christopher Corless including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 3296
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wood M, Beadling C, Neff T, Moore S, Harrington C, Baird L, et al.
Acta Neuropathol Commun . 2023 Sep; 11(1):143. PMID: 37670377
Diffuse gliomas are a heterogeneous category of primary central nervous system tumors. Due to their infiltrative growth precluding complete surgical resection, most diffuse high-grade gliomas are treated with adjuvant chemotherapy...
2.
Kung V, Avasare R, Friedman M, Koon S, Neff T, Protzek S, et al.
Kidney360 . 2023 Apr; 4(6):e759-e768. PMID: 37036681
No abstract available.
3.
Johnson B, Creason A, Stommel J, Keck J, Parmar S, Betts C, et al.
Cell Rep Med . 2022 Mar; 3(2):100525. PMID: 35243422
Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms...
4.
Schau G, Burlingame E, Thibault G, Anekpuritanang T, Wang Y, Gray J, et al.
J Med Imaging (Bellingham) . 2021 Sep; 7(1):012706. PMID: 34541020
: Pathologists rely on relevant clinical information, visual inspection of stained tissue slide morphology, and sophisticated molecular diagnostics to accurately infer the biological origin of secondary metastatic cancer. While highly...
5.
Filipits M, Preusser M, Hainfellner J, Spiegl-Kreinecker S, Berghoff A, Lai E, et al.
Anticancer Res . 2020 Oct; 40(11):6229-6236. PMID: 33109560
Background/aim: To compare the GeneXpert® O6-methylguanine DNA methyltransferase (MGMT) methylation prototype (GX MGMT) assay with pyrosequencing in glioblastomas. Materials And Methods: The MGMT methylation status was retrospectively assessed in formalin-fixed...
6.
Burlingame E, McDonnell M, Schau G, Thibault G, Lanciault C, Morgan T, et al.
Sci Rep . 2020 Oct; 10(1):17507. PMID: 33060677
Spatially-resolved molecular profiling by immunostaining tissue sections is a key feature in cancer diagnosis, subtyping, and treatment, where it complements routine histopathological evaluation by clarifying tumor phenotypes. In this work,...
7.
Azimi V, Chang Y, Thibault G, Smith J, Tsujikawa T, Kukull B, et al.
Proc IEEE Int Symp Biomed Imaging . 2018 Oct; 2017:1137-1140. PMID: 30364881
The translation of genomic sequencing technology to the clinic has greatly advanced personalized medicine. However, the presence of normal cells in tumors is a confounding factor in genome sequence analysis....
8.
Bannon A, Kent J, Forquer I, Town A, Klug L, McCann K, et al.
Clin Cancer Res . 2017 Jul; 23(21):6733-6743. PMID: 28724664
Patients who inherit a pathogenic loss-of-function genetic variant involving one of the four succinate dehydrogenase (SDH) subunit genes have up to an 86% chance of developing one or more cancers...
9.
Jennings L, Arcila M, Corless C, Kamel-Reid S, Lubin I, Pfeifer J, et al.
J Mol Diagn . 2017 Mar; 19(3):341-365. PMID: 28341590
Next-generation sequencing (NGS) methods for cancer testing have been rapidly adopted by clinical laboratories. To establish analytical validation best practice guidelines for NGS gene panel testing of somatic variants, a...
10.
Arnason T, Borger D, Corless C, Hagen C, Iafrate A, Makhlouf H, et al.
Am J Surg Pathol . 2017 Mar; 41(4):499-505. PMID: 28266931
Biliary adenofibroma is a rare primary hepatic neoplasm, recognized in the World Health Organization classification, although only 14 cases have been reported to date. This series includes extended follow-up from...